RxDoctor Payments Data

Gabriel Dascanio, PA

Physician Assistant · Winston Salem, NCNPI 1083215529

Payments from drug & device makers

$896in general payments, 2019–2025

Across 27 payments — averaging $33.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$324
  • Esperion Therapeutics, Inc.$120
  • AstraZeneca$105
  • Novo Nordisk$94
  • Bridgebio Pharma, Inc.$85
  • Abbott$64
  • plus $104 from 4 others

What the payments were for

  • Food & beverage$896100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$896 in reported general payments places this provider in the 65th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$19,027
Medicare patients
86
Services billed
201

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyndamaxTafamidis87$2,237,265
EntrestoSacubitril/Valsartan224$270,347
CamzyosMavacamten23$186,994
FarxigaDapagliflozin Propanediol106$89,776
JardianceEmpagliflozin86$88,952
EliquisApixaban70$74,451
XareltoRivaroxaban35$27,779
Torsemide102$2,279
Spironolactone273$2,170
Metoprolol Succinate147$1,696
Carvedilol81$553
Atorvastatin Calcium41$528
Hydralazine Hcl35$403
Verapamil ErVerapamil Hcl19$352
Potassium Chloride42$352

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerVyndamax, Eliquis$12$2,311,716157 claims
NovartisEntresto$25$270,347224 claims
AstraZenecaFarxiga$105$89,776106 claims
Johnson & JohnsonXarelto$324$27,77935 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →